Together, these studies indicate that ANGPT-2 is raised locally within the brain in disease conditions associated with cerebral vascular injury and BBB leakiness and raise the possibility that such upregulation would occur in the early stages of AD. The gene discussed is ANGPT2; the disease is Alzheimer disease.